Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2017 1
2020 1
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab for rheumatoid arthrits treatment: a systematic review.
de Lemos LL, Costa Jde O, Machado MA, Almeida AM, Barbosa MM, Kakehasi AM, de Araújo VE, Guerra Júnior AA, Acurcio Fde A. de Lemos LL, et al. Among authors: barbosa mm. Rev Bras Reumatol. 2014 May-Jun;54(3):220-30. Rev Bras Reumatol. 2014. PMID: 25054600 Free article. Review. English, Portuguese.
Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis.
Machado MA, Barbosa MM, Almeida AM, de Araújo VE, Kakehasi AM, Andrade EI, Cherchiglia ML, Acurcio Fde A. Machado MA, et al. Among authors: barbosa mm. Rheumatol Int. 2013 Sep;33(9):2199-213. doi: 10.1007/s00296-013-2772-6. Epub 2013 May 18. Rheumatol Int. 2013. PMID: 23686218 Review.
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta-analyses of observational studies.
Souza KM, Carrasco G, Rojas-Cortés R, Michel Barbosa M, Bambirra EHF, Castro JL, Alvares-Teodoro J. Souza KM, et al. Among authors: michel barbosa m. PLoS One. 2023 Oct 12;18(10):e0284006. doi: 10.1371/journal.pone.0284006. eCollection 2023. PLoS One. 2023. PMID: 37824507 Free PMC article.
Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab.
Camelo RM, Barbosa MM, Araújo MS, Muniz RL Jr, Guerra AA Jr, Godman B, Rezende SM, Acurcio FA, Martin AP, Alvares-Teodoro J. Camelo RM, et al. Among authors: barbosa mm. Value Health Reg Issues. 2023 Mar;34:31-39. doi: 10.1016/j.vhri.2022.10.007. Epub 2022 Dec 1. Value Health Reg Issues. 2023. PMID: 36463835 Free article.